<![CDATA[Regencell Bioscience Holdings Limited 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=38180>Mon, 20 Apr 2026 03:39:16 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period]]>https://www.newswire.co.kr/newsRead.php?no=944820Thu, 19 May 2022 16:00:00 +0900<![CDATA[리젠셀 바이오사이언스, 연구용 액상제제 ‘RGC-COV19™ EARTH’ 효능 시험 추가 결과 발표… 6일 치료 기간 내 경증 및 중등도 코로나19 증상 제거 효능 확증]]>https://www.newswire.co.kr/newsRead.php?no=944821Thu, 19 May 2022 16:00:00 +0900<![CDATA[Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO]]>https://www.newswire.co.kr/newsRead.php?no=944623Tue, 17 May 2022 11:40:00 +0900<![CDATA[리젠셀 바이오사이언스 홀딩스 CEO, 500만달러 이상의 자사주 매입]]>https://www.newswire.co.kr/newsRead.php?no=944624Tue, 17 May 2022 11:40:00 +0900<![CDATA[Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial]]>https://www.newswire.co.kr/newsRead.php?no=939919Tue, 22 Feb 2022 16:00:00 +0900<![CDATA[리젠셀의 연구용 액상 제제 RGC-COV19TM, EARTH 효능 시험에서 효과 6일 치료 기간 내 경증에서 중등도 코로나19 증상 사라져]]>https://www.newswire.co.kr/newsRead.php?no=939924Tue, 22 Feb 2022 16:00:00 +0900<![CDATA[Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering]]>https://www.newswire.co.kr/newsRead.php?no=927269Mon, 19 Jul 2021 09:45:00 +0900<![CDATA[리젠셀 바이오사이언스 홀딩스, 약 2190만달러의 기업공개 공모가 발표]]>https://www.newswire.co.kr/newsRead.php?no=927270Mon, 19 Jul 2021 09:45:00 +0900